MF Researcher Database

研究者一覧

詳細

吉村　清Yoshimura Kiyoshi

■所属部署名臨床薬理研究所臨床免疫腫瘍学
■職名教授
Last Updated :2025/04/01

研究者情報

基本情報

プロフィール情報

  • 氏名

    吉村　清, Yoshimura Kiyoshi

所属

  • 臨床薬理研究所臨床免疫腫瘍学, 教授

施設

  • 烏山病院

学位

  • 博士(医学), 山口大学, 2001年03月

業績

論文

  • Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor., Kazuyuki Hamada, Junya Isobe, Kouya Hattori, Masahiro Hosonuma, Yuta Baba, Masakazu Murayama, Yoichiro Narikawa, Hitoshi Toyoda, Eiji Funayama, Kohei Tajima, Midori Shida, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Ryotaro Ohkuma, Yutaro Kubota, Takehiko Sambe, Mayumi Tsuji, Satoshi Wada, Yuji Kiuchi, Shinichi Kobayashi, Atsuo Kuramasu, Atsushi Horiike, Yun-Gi Kim, Takuya Tsunoda and Kiyoshi Yoshimura, Front Immunol., 14:1164724, 2023年05月, 原著, 査読あり, DOI:10.3389/fimmu.2023.1164724
  • Association of microbiota with cancer treatment., Yoshimura Kiyoshi, International journal of clinical oncology, 28(3):341 - 346, 2023年02月, 総説
  • 【気管食道科領域における免疫チェックポイント阻害薬の現状】気管食道科領域における免疫チェックポイント阻害薬の現状, 村山 正和;細沼 雅弘;倉増 敦朗;吉村 清, 日本気管食道科学会会報, 73(5):308 - 317, 2022年10月
  • Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors., Hamada Kazuyuki;Tsunoda Takuya;Yoshimura Kiyoshi, Life (Basel, Switzerland), 12(8):1229, 2022年08月, 総説
  • Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells., Kimura Yuta;Tsunedomi Ryouichi;Yoshimura Kiyoshi;Matsukuma Satoshi;Shindo Yoshitaro;Matsui Hiroto;Tokumitsu Yukio;Yoshida Shin;Iida Michihisa;Suzuki Nobuaki;Takeda Shigeru;Ioka Tatsuya;Hazama Shoichi;Nagano Hiroaki, Annals of surgical oncology, 29(12):7423 - 7433, 2022年07月
  • 今後のがん免疫療法の流れ, 成川 陽一郎;細沼 雅弘;倉増 敦朗;吉村 清, 腫瘍内科, 30(1):67, 2022年07月
  • 【消化器癌に対する免疫療法の進歩】免疫療法と腸内細菌, 細沼 雅弘;吉村 清, 消化器・肝臓内科, 11(5):634 - 641, 2022年05月
  • 【腫瘍免疫-免疫ネットワークから考える基礎と臨床】ネットワークの各因子と、その因子を応用or標的とした基礎研究の現在と可能性　がん免疫ネットワークに影響を与える因子　腸内細菌とがん免疫微小環境, 細沼 雅弘;吉村 清, 医学のあゆみ, 281(5):401 - 407, 2022年04月
  • A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report., Hamada Kazuyuki;Yoshimura Kiyoshi;Oshinomi Kazuhiko;Hirasawa Yuya;Ariizumi Hirotsugu;Ohkuma Ryotaro;Shida Midori;Kubota Yutaro;Matsui Hiroto;Ishiguro Tomoyuki;Sambe Takehiko;Ishida Hiroo;Horiike Atsushi;Wada Satoshi;Iwamoto Sanju;Uchida Naoki;Ogawa Yoshio;Kobayashi Shinichi;Tsunoda Takuya, Medicine, 101(2):e28339, 2022年01月, 原著
  • Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy., Kazuyuki Hamada; Kiyoshi Yoshimura; Yuya Hirasawa; Masahiro Hosonuma; Masakazu Murayama; Yoichiro Narikawa; Hirotsugu Ariizumi; Ryotaro Ohkuma; Midori Shida; Yutaro Kubota; Satoshi Matsukuma; Tomoyuki Ishiguro; Takehiko Sambe; Atsushi Horiike; Atsuo Kuramasu; Satoshi Wada; Junji Tsurutani; Eisuke Inoue; Naoki Uchida; Yuji Kiuchi; Shinichi Kobayashi; Robert M Hoffman; Takuya Tsunoda, Anticancer research, 41(10):4985 - 4993, 2021年10月
  • Reduced expression of programmed cell death 1 and programmed cell death ligand 1 in infiltrating inflammatory cells of lichen planus without administration of immune checkpoint inhibitors., Kazufumi Shirouchi; Sachiko Koshikawa; Koichiro Shinya; Hideaki Watanabe; Miki Izumi; Kiyoshi Yoshimura; Hirohiko Sueki, The Journal of dermatology, 48(9):1428 - 1432, 2021年09月
  • [Gut Microbiota and Tumor Immune Microenvironment]., Kiyoshi Yoshimura; Takuya Tsunoda, Gan to kagaku ryoho. Cancer & chemotherapy, 48(9):1103 - 1108, 2021年09月
  • 治療抵抗性肝癌幹細胞様Sphere細胞におけるRAB3Bの役割, 恒富 亮一; 吉村 清; 松隈 聡; 松井 洋人; 兼清 信介; 新藤 芳太郎; 飯田 通久; 鈴木 伸明; 武田 茂; 井岡 達也; 硲 彰一; 永野 浩昭, 日本癌学会総会記事, 80回:[J11 - 2], 2021年09月
  • がん免疫療法の最新情報と腸内細菌, 吉村　清, 昭和学士会雑誌, 81(3):166 - 170, 2021年08月, 査読あり
  • Calcium/calmodulin-dependent regulation of Rac GTPases and Akt in histamine-induced chemotaxis of mast cells., Takeshi Honda; Yusuke Nishio; Hiroki Sakai; Masataka Asagiri; Kiyoshi Yoshimura; Makoto Inui; Atsuo Kuramasu, Cellular signalling, 83:109973 - 109973, 2021年07月
  • A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy., Yuya Hirasawa; Kiyoshi Yoshimura; Hiroto Matsui; Yutaro Kubota; Hiroo Ishida; Jun Arai; Masashi Sakaki; Nao Oguro; Midori Shida; Makoto Taniguchi; Kazuyuki Hamada; Hirotsugu Ariizumi; Tomoyuki Ishiguro; Ryotaro Ohkuma; Takehiko Sambe; Atsushi Horiike; Chiyo K Imamura; Eisuke Shiozawa; Satoshi Wada; Junji Tsurutani; Sanju Iwamoto; Naoki Uchida; Yuji Kiuchi; Genshu Tate; Shinichi Kobayashi; Takuya Tsunoda, Medicine, 100(23):e25774, 2021年06月
  • A Phase I/IIa Study of Antidisialoganglioside Antibody Dinutuximab in Japanese Patients With Neuroblastoma., HARA J;NITANI C;KAWAMOTO H;TAGUCHI T;KIMURA T;YOSHIMURA K;YOSHIMURA Kiyoshi, J Pediatr Hematol Oncol, 43(3):e358 - e364, 2021年04月, 原著, 査読あり, DOI:10.1097/MPH.0000000000001684
  • CathepsinBは膵癌stem like cellsに高発現し、治癒切除後の予後と関連している, 藤本 拓也; 恒富 亮一; 松隈 聰; 吉村 清; 小賀 厚徳; 松井 洋人; 新藤 芳太郎; 徳光 幸生; 小林 省吾; 井岡 達也; 江口 英利; 永野 浩昭, 日本外科学会定期学術集会抄録集, 121回:PS - 1, 2021年04月
  • Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance., Yasuhiro Fujiwara; Ryouichi Tsunedomi; Kiyoshi Yoshimura; Satoshi Matsukuma; Nobuyuki Fujiwara; Mitsuo Nishiyama; Shinsuke Kanekiyo; Hiroto Matsui; Yoshitaro Shindo; Yukio Tokumitsu; Shin Yoshida; Michihisa Iida; Nobuaki Suzuki; Shigeru Takeda; Tatsuya Ioka; Shoichi Hazama; Hiroaki Nagano, Pancreas, 50(3):405 - 413, 2021年03月
  • Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes., Takuya Fujimoto; Ryouichi Tsunedomi; Satoshi Matsukuma; Kiyoshi Yoshimura; Atsunori Oga; Nobuyuki Fujiwara; Yasuhiro Fujiwara; Hiroto Matsui; Yoshitaro Shindo; Yukio Tokumitsu; Nobuaki Suzuki; Shogo Kobayashi; Shoichi Hazama; Hidetoshi Eguchi; Hiroaki Nagano, Oncology letters, 21(1):30 - 30, 2021年01月
  • High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer., Ryotaro Ohkuma; Erica Yada; Shumpei Ishikawa; Daisuke Komura; Yutaro Kubota; Kazuyuki Hamada; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Midori Shida; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada, International journal of oncology, 58(1):57 - 69, 2021年01月
  • 肝癌幹細胞におけるRAB3Bの機能解析, 恒富 亮一; 吉村 清; 松隈 聰; 徳光 幸生; 新藤 芳太郎; 松井 洋人; 鈴木 伸明; 武田 茂; 硲 彰一; 永野 浩昭, 日本消化器外科学会総会, 75回:P219 - 5, 2020年12月
  • 肝臓 再発・転移, 恒富 亮一; 吉村 清; 木村 祐太; 西山 光郎; 松隈 聰; 新藤 芳太郎; 徳光 幸生; 友近 忍; 吉田 晋; 飯田 通久; 鈴木 伸明; 武田 茂; 吉野 茂文; 硲 彰一; 永野 浩昭, 日本消化器外科学会雑誌, 53(Suppl.2):236 - 236, 2020年11月
  • 治療抵抗性肝癌幹細胞様Sphere細胞におけるRAB3B遺伝子, 恒富 亮一; 吉村 清; 松隈 聰; 松井 洋人; 兼清 伸介; 新藤 芳太郎; 徳光 幸生; 飯田 通久; 鈴木 伸明; 武田 茂; 井岡 達也; 硲 彰一; 永野 浩昭, 日本癌学会総会記事, 79回:OE11 - 3, 2020年10月
  • 誘導癌幹細胞における免疫逃避機構の検討, 恒富 亮一; 吉村 清; 木村 祐太; 西山 光朗; 松隈 聰; 兼清 信介; 徳光 幸生; 友近 忍; 吉田 晋; 飯田 通久; 鈴木 伸明; 武田 茂; 井岡 達也; 硲 彰一; 永野 浩昭, 日本癌治療学会学術集会抄録集, 58回:O59 - 1, 2020年10月
  • A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors., Kiyohiro Ando; Kazuyuki Hamada; Midori Shida; Ryotaro Ohkuma; Yutaro Kubota; Atsushi Horiike; Hiroto Matsui; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Makoto Watanabe; Rie Onoue; Junji Tsurutani; Kiyoshi Yoshimura; Takuya Tsunoda; Shinichi Kobayashi; Satoshi Wada, Cancer immunology, immunotherapy : CII, 70(2):337 - 348, 2020年08月
  • High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer., Ryotaro Ohkuma; Erica Yada; Shumpei Ishikawa; Daisuke Komura; Yutaro Kubota; Kazuyuki Hamada; Atsushi Horiike; Tomoyuki Ishiguro; Yuya Hirasawa; Hirotsugu Ariizumi; Midori Shida; Makoto Watanabe; Rie Onoue; Kiyohiro Ando; Junji Tsurutani; Kiyoshi Yoshimura; Tetsuro Sasada; Takeshi Aoki; Masahiko Murakami; Tomoko Norose; Nobuyuki Ohike; Masafumi Takimoto; Shinichi Kobayashi; Takuya Tsunoda; Satoshi Wada, Oncology reports, 44(1):252 - 262, 2020年07月
  • Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact., TSUNEDOMI R;YOSHIMURA Kiyoshi;SUZUKI N;HAZAMA S;NAGANO H, Surg Today, :1 - 17, 2020年02月, 総説, 査読あり
  • Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers., KIKUCHI T;MIMURA K;ASHIZAWA M;OKAYAMA H;ENDO E;SAITO K;SAKAMOTO W;FUJITA S;ENDO H;SAITO M;MOMMA T;SAZE Z;OHKI S;SHIMADA Kazunori;YOSHIMURA Kiyoshi;TSUNODA Takuya;KONO K, Cancer Immunol Immunother, 69(1):23 - 32, 2020年01月, 原著, 査読あり
  • Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers., KIKUCHI T;MIMURA K;ASHIZAWA M;OKAYAMA H;ENDO E;SAITO K;SAKAMOTO W;FUJITA S;ENDO H;SAITO M;MOMMA T;SAZE Z;OHKI S;SHIMADA Kazunori; IEGUCHI Katsuaki;TOMITA Takeshi;TAKAO Toshifumi;OMORI Tsutomu;MISHIMA;TSUNODA Takuya;KONO K, Cancer Immunol Immunother, 69(1):23 - 32, 2020年01月, 原著, 査読あり
  • High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer., OHKUMA Ryotaro;YADA Erica;ISHIKAWA Shumpei;KOMURA Daisuke;ISHIZAKI Hidenobu;TAMADA Koji;KUBOTA Yutaro;HAMADA Kazuyuki;ISHIDA Hiroo;HIRASAWA Yuya;ARIIZUMI Hirotsugu;SATOH Etsuko;SHIDA Midori;WATANABE Makoto;ONOUE Rie;ANDO Kiyohiro;TSURUTANI Junji;YOSHIMURA Kiyoshi;YOKOBORI Takehiko;SASADA Tetsuro;AOKI Takeshi;MURAKAMI Masahiko;NOROSE Tomoko;OHIKE Nobuyuki;TAKIMOTO Masafumi;IZUMIZAKI Masahiko;KOBAYASHI Shinichi;TSUNODA Takuya;WADA Satoshi, PloS One, 15(1):e0226707, 2020年01月, 原著, 査読あり
  • Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors, ANDO Kiyohiro;HAMADA Kazuyuki;WATANABE Makoto;OHKUMA Ryotaro;SHIDA Midori;ONOUE Rie;KUBOTA Yutaro;MATSUI Hiroto;ISHIGURO Tomoyuki;HIRASAWA Yuya;ARIIZUMI Hirotsugu;TSURUTANI Junji;YOSHIMURA Kiyoshi;TSUNODA Takuya;KOBAYASHI Shinichi;WADA Satoshi, Anticancer Res, 39(9):5195 - 5201, 2019年09月, 原著, 査読あり
  • 腎癌および尿路上皮癌患者におけるバイオマーカー探索のための腸内細菌叢の研究, 下山　英明;直江　道夫;サト　プラサド　ネパール;平松　綾;松井　祐輝;鵜木　勉;中里　武彦;押野見　和彦;森田　順;前田　佳子;冨士　幸藏;小川　良雄;角田　卓也;吉村　清, 昭和学士会雑誌, 79(4):492 - 504, 2019年08月, 原著, 査読あり
  • Gut microbiotaが切り拓くがん免疫療法の未来, 吉村 清; 和田 聡; 三邉 武彦; 内田 直樹; 木内 祐二; 小林 真一; 角田 卓也; 濵田 和幸; 谷口 誠; 平澤 優弥; 志田 みどり; 萬﨑 貴士; 石田 博雄; 久保田 祐太郎; 鶴谷 純司, 日本薬理学会年会要旨集, 92(0):3 - JS4-1, 2019年
  • What is the checkpoint of the immunotherapy against GI cancer?, Yoshimura, Kiyoshi; Wada, Satoshi; Tsunoda, Takuya, CANCER SCIENCE, 109:371 - 371, 2018年12月
  • 膵癌幹細胞に高発現した分子calreticulinの臨床的意義, 松隈 聰; 吉村 清; 藤原 康弘; 井上 萌子; 布施 雅規; 小賀 厚徳; 恒富 亮一; 徳光 幸生; 徳久 善弘; 坂本 和彦; 兼清 信介; 友近 忍; 飯田 通久; 鈴木 伸明; 武田 茂; 吉野 茂文; 硲 彰一; 江口 英利; 上野 富雄; 永野 浩昭, 日本消化器外科学会雑誌, 51(Suppl.2):193 - 193, 2018年11月
  • Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells., Mitsuo Nishiyama; Ryouichi Tsunedomi; Kiyoshi Yoshimura; Noriaki Hashimoto; Satoshi Matsukuma; Hiroyuki Ogihara; Shinsuke Kanekiyo; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Takeda; Shigeru Yamamoto; Shigefumi Yoshino; Tomio Ueno; Yoshihiko Hamamoto; Shoichi Hazama; Hiroaki Nagano, Cancer science, 109(4):1101 - 1109, 2018年04月
  • Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy., Ryoji Kamei; Kiyoshi Yoshimura; Shigefumi Yoshino; Moeko Inoue; Tetsuhiko Asao; Masanori Fuse; Satoshi Wada; Atsuo Kuramasu; Tomoko Furuya-Kondo; Atsunori Oga; Norio Iizuka; Nobuaki Suzuki; Noriko Maeda; Yusaku Watanabe; Satoshi Matsukuma; Michihisa Iida; Shigeru Takeda; Tomio Ueno; Noboru Yamamoto; Takeo Fukagawa; Hitoshi Katai; Hiroki Sasaki; Shoichi Hazama; Masaaki Oka; Hiroaki Nagano, Oncology letters, 15(1):747 - 754, 2018年01月
  • 膵癌幹細胞の新たな表面マーカーcalreticulinの同定, 松隈 聡; 吉村 清; 江口 英利; 恒富 亮一; 松井 洋人; 兼清 信介; 徳光 幸生; 友近 忍; 徳久 善弘; 飯田 通久; 坂本 和彦; 鈴木 伸明; 武田 茂; 吉野 茂文; 硲 彰一; 上野 富雄; 永野 浩昭, 日本消化器外科学会雑誌, 50(Suppl.2):420 - 420, 2017年10月
  • Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy., Hiroto Matsui; Shoichi Hazama; Kazuhiko Sakamoto; Yoshitaro Shindo; Shinsuke Kanekiyo; Masao Nakashima; Satoshi Matsukuma; Yoshihiro Tokuhisa; Michihisa Iida; Nobuaki Suzuki; Kiyoshi Yoshimura; Shigeru Takeda; Tomio Ueno; Shigefumi Yoshino; Masaaki Oka; Hiroaki Nagano, Pancreas, 46(8):994 - 1002, 2017年09月
  • Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models., Ayano Konagai; Kiyoshi Yoshimura; Shouichi Hazama; Noboru Yamamoto; Kazunori Aoki; Tomio Ueno; Masaki Fujioka; Hiroko Iijima; Mariko Kato; Motoyuki Uchida; Tsutomu Wada; Moeko Inoue; Tetsuhiko Asao; Masanori Fuse; Satoshi Wada; Atsuo Kuramasu; Ryoji Kamei; Shigeru Takeda; Shigeru Yamamoto; Shigefumi Yoshino; Masaaki Oka; Hiroaki Nagano, Anticancer research, 37(8):4093 - 4101, 2017年08月
  • Expression levels of UL16 binding protein 1 and natural killer group 2 member D in patients with gastric cancer, Yoshimura, Kiyoshi; Inoue, Moeko; Asao, Tetsuhiko; Fuse, Masanori; Wada, Satoshi; Kuramasu, Atsuo, CANCER RESEARCH, 77, 2017年07月
  • Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma., Shinichi Makita; Kiyoshi Yoshimura; Kensei Tobinai, Cancer science, 108(6):1109 - 1118, 2017年06月
  • The development status of the next-generation immune checkpoint inhibitors., Masanori Fuse; Kiyoshi Yoshimura, Nihon rinsho. Japanese journal of clinical medicine, 75(2):245 - 250, 2017年02月
  • Calreticulin is highly expressed in pancreatic cancer stem-like cells., Satoshi Matsukuma; Kiyoshi Yoshimura; Tomio Ueno; Atsunori Oga; Moeko Inoue; Yusaku Watanabe; Atsuo Kuramasu; Masanori Fuse; Ryouichi Tsunedomi; Satoshi Nagaoka; Hidetoshi Eguchi; Hiroto Matsui; Yoshitaro Shindo; Noriko Maeda; Yoshihiro Tokuhisa; Reo Kawano; Tomoko Furuya-Kondo; Hiroshi Itoh; Shigefumi Yoshino; Shoichi Hazama; Masaaki Oka; Hiroaki Nagano, Cancer science, 107(11):1599 - 1609, 2016年11月
  • Breast sentinel lymph node navigation with three-dimensional computed tomography-lymphography: a 12-year study., Shigeru Yamamoto; Kazuyoshi Suga; Kazunari Maeda; Noriko Maeda; Kiyoshi Yoshimura; Masaaki Oka, Breast cancer (Tokyo, Japan), 23(3):456 - 62, 2016年05月
  • Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial., Yoshinari Maeda; Kiyoshi Yoshimura; Hiroto Matsui; Yoshitaro Shindo; Takao Tamesa; Yukio Tokumitsu; Noriaki Hashimoto; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Kouhei Sakai; Yutaka Suehiro; Yuji Hinoda; Koji Tamada; Shigefumi Yoshino; Shoichi Hazama; Masaaki Oka, Cancer immunology, immunotherapy : CII, 64(8):1047 - 56, 2015年08月
  • Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion., Yukio Tokumitsu; Shigefumi Yoshino; Michihisa Iida; Kiyoshi Yoshimura; Tomio Ueno; Shoichi Hazama; Masaaki Oka, Surgery today, 45(6):746 - 51, 2015年06月
  • Combination immunotherapy with 4-1BB activation and PD-1 blockade enhances antitumor efficacy in a mouse model of subcutaneous tumor., Yoshitaro Shindo; Kiyoshi Yoshimura; Atsuo Kuramasu; Yusaku Watanabe; Hideaki Ito; Tomoko Kondo; Atsunori Oga; Hiroshi Ito; Shigefumi Yoshino; Shoichi Hazama; Koji Tamada; Hideo Yagita; Masaaki Oka, Anticancer research, 35(1):129 - 36, 2015年01月
  • Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice., Susumu Ishiguro; Kiyoshi Yoshimura; Ryouichi Tsunedomi; Masaaki Oka; Sonshin Takao; Makoto Inui; Atsushi Kawabata; Terrahn Wall; Vassiliki Magafa; Paul Cordopatis; Andreas G Tzakos; Masaaki Tamura, Cancer biology & therapy, 16(2):307 - 16, 2015年
  • Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients., N Maeda; K Yoshimura; S Yamamoto; A Kuramasu; M Inoue; N Suzuki; Y Watanabe; Y Maeda; R Kamei; R Tsunedomi; Y Shindo; M Inui; K Tamada; S Yoshino; S Hazama; M Oka, Annals of Surgical Oncology, 21 Suppl 4:S546-54 - S554, 2014年12月
  • A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population., Yusaku Watanabe; Kiyoshi Yoshimura; Koichi Yoshikawa; Ryoichi Tsunedomi; Yoshitaro Shindo; Sou Matsukuma; Noriko Maeda; Shinsuke Kanekiyo; Nobuaki Suzuki; Atsuo Kuramasu; Kouhei Sonoda; Koji Tamada; Sei Kobayashi; Hideyuki Saya; Shoichi Hazama; Masaaki Oka, International journal of oncology, 45(5):1857 - 66, 2014年11月
  • [Clinical benefit of thoracoscopic approach for liver tumors located under the diaphragm]., Takao Tamesa; Kazuhiko Sakamoto; Noriaki Hashimoto; Yukio Tokumitsu; Yoshitaro Shindo; Michihisa Iida; Yoshihiro Tokuhisa; Yoshinari Maeda; Nobuaki Suzuki; Kiyoshi Yoshimura; Tomio Ueno; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 41(12):1500 - 2, 2014年11月
  • A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model., Kosuke Higashi; Shoichi Hazama; Atsuhiro Araki; Kiyoshi Yoshimura; Norio Iizuka; Shigefumi Yoshino; Takafumi Noma; Masaaki Oka, International journal of oncology, 45(4):1412 - 20, 2014年10月
  • 当科における肥満症例に対する膵頭十二指腸切除術の検討, 鈴木 伸明; 上野 富雄; 松井 洋人; 徳光 幸生; 新藤 芳太郎; 橋本 憲輝; 前田 祥成; 徳久 善弘; 飯田 通久; 坂本 和彦; 吉村 清; 為佐 卓夫; 吉野 茂文; 硲 彰一; 岡 正朗, 日本消化器外科学会雑誌, 47(Suppl.2):268 - 268, 2014年10月
  • 当科における非B非C型肝細胞癌の臨床病理学的検討, 爲佐 卓夫; 坂本 和彦; 徳光 幸生; 橋本 憲輝; 前田 祥成; 徳久 善弘; 松隈 聰; 松井 洋人; 新藤 芳太郎; 飯田 通久; 鈴木 伸明; 吉村 清; 上野 富雄; 岡 正朗, 日本消化器外科学会雑誌, 47(Suppl.2):206 - 206, 2014年10月
  • A preclinical murine model of hepatic metastases., Kevin C Soares; Kelly Foley; Kelly Olino; Ashley Leubner; Skye C Mayo; Ajay Jain; Elizabeth Jaffee; Richard D Schulick; Kiyoshi Yoshimura; Barish Edil; Lei Zheng, Journal of visualized experiments : JoVE, (91):51677 - 51677, 2014年09月
  • Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs., Noriaki Hashimoto; Ryouichi Tsunedomi; Kiyoshi Yoshimura; Yusaku Watanabe; Shoichi Hazama; Masaaki Oka, BMC cancer, 14:722 - 722, 2014年09月
  • Predictive biomarkers for the outcome of vaccination of five therapeutic epitope peptides for colorectal cancer., Shoichi Hazama; Hiroko Takenouchi; Ryouichi Tsunedomi; Michihisa Iida; Nobuaki Suzuki; Norio Iizuka; Yuka Inoue; Kazuhiko Sakamoto; Mitsuhiro Nakao; Yoshitaro Shindo; Shinsuke Kanekiyo; Yukio Tokumitsu; Kiyoshi Yoshimura; Noriko Maeda; Kazunari Maeda; Yoshinari Maeda; Hiroto Matsui; Shigefumi Yoshino; Yusuke Nakamura; Yusuke Fujita; Yoshihiko Hamamoto; Masato Okamoto; Tomonobu Fujita; Yutaka Kawakami; Masaaki Oka, Anticancer research, 34(8):4201 - 5, 2014年08月
  • Relationship between cytokine gene polymorphisms and risk of postoperative pneumonia with esophageal cancer., Kazuhiko Sakamoto; Masaaki Oka; Shigehumi Yoshino; Shoichi Hazama; Shigeru Takeda; Kiyoshi Yoshimura; Naoko Okayama; Yuji Hinoda, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 18(7):1247 - 53, 2014年07月
  • Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer., Yoshitaro Shindo; Shoichi Hazama; Yoshinari Maeda; Hiroto Matsui; Michihisa Iida; Nobuaki Suzuki; Kiyoshi Yoshimura; Tomio Ueno; Shigefumi Yoshino; Kohei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Yuji Hinoda; Masaaki Oka, Journal of translational medicine, 12:175 - 175, 2014年06月
  • A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer., Nobuaki Suzuki; Shoichi Hazama; Tomio Ueno; Hiroto Matsui; Yoshitaro Shindo; Michihisa Iida; Kiyoshi Yoshimura; Shigefumi Yoshino; Kazuyoshi Takeda; Masaaki Oka, Journal of immunotherapy (Hagerstown, Md. : 1997), 37(1):36 - 42, 2014年01月
  • Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model., Satoshi Wada; Timothy J Harris; Erik Tryggestad; Kiyoshi Yoshimura; Jing Zeng; Hung-Rong Yen; Derese Getnet; Joseph F Grosso; Tullia C Bruno; Angelo M De Marzo; George J Netto; Drew M Pardoll; Theodore L DeWeese; John Wong; Charles G Drake, International journal of radiation oncology, biology, physics, 87(4):769 - 76, 2013年11月
  • [A case of hepatocellular carcinoma with Vp4 tumor thrombus treated by radiation therapy before hepatectomy]., Takao Tamesa; Kazuhiko Sakamoto; Taichi Kuwahara; Noriaki Hashimoto; Yukio Tokumitsu; Yoshitaro Shindo; Michihisa Iida; Yoshihiro Tokuhisa; Yoshinari Maeda; Nobuaki Suzuki; Kiyoshi Yoshimura; Tomio Ueno; Shigefumi Yoshino; Shoichi Hazama; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 40(12):1807 - 9, 2013年11月
  • [A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]., Kensuke Yamada; Kazuhiko Sakamoto; Takao Tamesa; Hiroto Matsui; Yoshitaro Shindo; Yukio Tokumitsu; Noriaki Hashimoto; Michihisa Iida; Yoshinari Maeda; Yoshihiro Tokuhisa; Nobuaki Suzuki; Kiyoshi Yoshimura; Tomio Ueno; Masataro Takahashi; Keiko Shibuya; Tomoko Kondo; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 40(12):1756 - 8, 2013年11月
  • Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography., Shigeru Yamamoto; Noriko Maeda; Kiyoshi Yoshimura; Masaaki Oka, Breast (Edinburgh, Scotland), 22(5):933 - 7, 2013年10月
  • ヒト膵癌細胞株を用いた癌幹細胞が豊富な細胞集団の誘導, 吉村 清; 渡邊 裕策; 恒富 亮一; 新藤 芳太郎; 前田 祥成; 松井 洋人; 前田 訓子; 橋本 憲輝; 鈴木 伸明; 上野 富雄; 山本 滋; 吉野 茂文; 硲 彰一; 岡 正朗, 日本消化器外科学会雑誌, 46(Suppl.2):166 - 166, 2013年10月
  • 切除不能大腸癌に対する1次治療としてのbiweekly XELOX+Cetuximab療法, 鈴木 伸明; 硲 彰一; 田中 宏典; 来嶋 大樹; 井上 由佳; 徳光 幸生; 兼清 信介; 中尾 光宏; 前田 祥成; 飯田 通久; 吉村 清; 吉野 茂文; 岡 正朗, 日本消化器外科学会雑誌, 46(Suppl.2):242 - 242, 2013年10月
  • 根治切除を目指した仙骨浸潤を伴う直腸癌に対する治療戦略, 田中 宏典; 硲 彰一; 徳光 幸生; 井上 由佳; 松井 洋人; 北原 正博; 新藤 芳太郎; 橋本 憲輝; 鈴木 伸明; 吉村 清; 上野 富雄; 吉野 茂文; 岡 正朗, 日本消化器外科学会雑誌, 46(Suppl.2):248 - 248, 2013年10月
  • 膵癌術後補助療法としてのGEM併用MUC1-CTL療法, 松井 洋人; 硲 彰一; 徳光 幸生; 橋本 憲輝; 新藤 芳太郎; 前田 祥成; 飯田 通久; 徳久 善弘; 坂本 和彦; 鈴木 伸明; 為佐 卓夫; 吉村 清; 上野 富雄; 吉野 茂文; 岡 正朗, 日本消化器外科学会雑誌, 46(Suppl.2):168 - 168, 2013年10月
  • ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma., Ryouichi Tsunedomi; Norio Iizuka; Kiyoshi Yoshimura; Michihisa Iida; Masahito Tsutsui; Noriaki Hashimoto; Shinsuke Kanekiyo; Kazuhiko Sakamoto; Takao Tamesa; Masaaki Oka, International journal of oncology, 42(5):1551 - 9, 2013年05月
  • Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer., Satoshi Wada; Christopher M Jackson; Kiyoshi Yoshimura; Hung-Rong Yen; Derese Getnet; Timothy J Harris; Monica V Goldberg; Tullia C Bruno; Joseph F Grosso; Nicholas Durham; George J Netto; Drew M Pardoll; Charles G Drake, Journal of translational medicine, 11:89 - 89, 2013年04月
  • Overexpression of the RD RNA binding protein in hepatitis C virus-related hepatocellular carcinoma., Michihisa Iida; Norio Iizuka; Ryouichi Tsunedomi; Masahiro Tsutsui; Shin Yoshida; Yoshinari Maeda; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Kiyoshi Yoshimura; Takao Tamesa; Masaaki Oka, Oncology reports, 28(2):728 - 34, 2012年08月
  • Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases., Kelly Olino; Satoshi Wada; Barish H Edil; Xiaoyu Pan; Kristen Meckel; Walter Weber; Jill Slansky; Koji Tamada; Peter Lauer; Dirk Brockstedt; Drew Pardoll; Richard Schulick; Kiyoshi Yoshimura, Annals of surgical oncology, 19 Suppl 3:S597-607 - 607, 2012年07月
  • Glycolipid antigens for treating hepatic colorectal cancer metastases and their effect on the therapeutic efficacy of live attenuated Listeria monocytogenes., Kelly Olino; Barish H Edil; Kristen F Meckel; Xiaoyu Pan; Avesh Thuluvath; Drew M Pardoll; Richard D Schulick; Kiyoshi Yoshimura; Walter P Weber, Archives of surgery (Chicago, Ill. : 1960), 147(5):480 - 2, 2012年05月
  • The intraductal injection of 5-fluorouracil for breast cancer: Preventive effect and immune response., Mori Tsuyoshi; Wada Satoshi; Olino Kelly; Edil Barish H; Pardoll Drew M; Schulick Richard D; Sukumar Saraswati; Yoshimura Kiyoshi, JOURNAL OF CLINICAL ONCOLOGY, 30(15), 2012年05月
  • Prospective ultrasonographic prediction of sentinel lymph node metastasis by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography in breast cancer patients., Shigeru Yamamoto; Noriko Maeda; Michiko Tamesa; Yukiko Nagashima; Kiyoshi Yoshimura; Masaaki Oka, Breast cancer (Tokyo, Japan), 19(1):77 - 82, 2012年01月
  • Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity., Kazunari Maeda; Shoichi Hazama; Kazuhisa Tokuno; Shin Kan; Yoshinari Maeda; Yusaku Watanabe; Ryoji Kamei; Yoshitaro Shindo; Noriko Maeda; Kiyoshi Yoshimura; Shigefumi Yoshino; Masaaki Oka, Anticancer research, 31(12):4569 - 74, 2011年12月
  • The intraductal injection of 5-fluorouracil induces immune response to eradicate and prevent breast cancer, Mori Tsuyoshi; Wada Satoshi; Olino Kelly; Weber Walter; Edil Barish; Meckel Kristen; Pan Xiaoyu; Pardoll Drew; Schulick Richard; Sukumar Saraswati; Yoshimura Kiyoshi, CANCER RESEARCH, 71, 2011年04月
  • [Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer]., Shigefumi Yoshino; Kiyoshi Yoshimura; Nobuaki Suzuki; Michihisa Iida; Shin Yoshida; Yoshinari Maeda; Kazunari Maeda; Shoichi Hazama; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 37(12):2234 - 6, 2010年11月
  • [Genetic diagnosis of intestinal cancer]., Kiyoshi Yoshimura; Masaaki Oka; Kenzaburo Tani, Nihon rinsho. Japanese journal of clinical medicine, 68 Suppl 8:451 - 7, 2010年08月
  • Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer)., Kiyoshi Yoshimura; Kelly Olino; Barish H Edil; Richard D Schulick; Masaaki Oka, Surgery today, 40(5):404 - 10, 2010年05月
  • Modulation of immune checkpoint B7-H1/B7-DC/PD-1 interaction in combination with live attenuated Listeria monocytogenes expressing a tumor associated antigen effectively treats hepatic colorectal cancer metastases, Yoshimura, Kiyoshi; Olino, Kelly; Edil, Barish; Wada, Satoshi; Pan, Xiaoyu; Meckel, Kristen; Pardoll, Drew; Schulick, Richard, CANCER RESEARCH, 70, 2010年04月
  • Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination., Vedran Radojcic; Karl B Bezak; Mario Skarica; Maria A Pletneva; Kiyoshi Yoshimura; Richard D Schulick; Leo Luznik, Cancer immunology, immunotherapy : CII, 59(1):137 - 48, 2010年01月
  • Integrin alpha2 mediates selective metastasis to the liver., Kiyoshi Yoshimura; Kristen F Meckel; Lindsay S Laird; Christina Y Chia; Jang-June Park; Kelly L Olino; Ryouichi Tsunedomi; Toshio Harada; Norio Iizuka; Shoichi Hazama; Yukihiko Kato; Jesse W Keller; John M Thompson; Fumin Chang; Lewis H Romer; Ajay Jain; Christine Iacobuzio-Donahue; Masaaki Oka; Drew M Pardoll; Richard D Schulick, Cancer research, 69(18):7320 - 8, 2009年09月
  • Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae?, Richard D Schulick; Kiyoshi Yoshimura, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 13(7):1184 - 6, 2009年07月
  • Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model., Satoshi Wada; Kiyoshi Yoshimura; Edward L Hipkiss; Tim J Harris; Hung-Rong Yen; Monica V Goldberg; Joseph F Grosso; Derese Getnet; Angelo M Demarzo; George J Netto; Robert Anders; Drew M Pardoll; Charles G Drake, Cancer research, 69(10):4309 - 18, 2009年05月
  • Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus setting., Tomoharu Miyashita; Furhawn A Shah; Guy P Marti; Todd D Armstrong; Jiaai Wang; Pramod Bonde; Michael K Gibson; Kiyoshi Yoshimura; Elizabeth A Montgomery; Mark Duncan; Elizabeth M Jaffee; John W Harmon, Digestive diseases and sciences, 53(11):2858 - 67, 2008年11月
  • Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells., Kiyoshi Yoshimura; Lindsay S Laird; Christina Y Chia; Kristen F Meckel; Jill E Slansky; John M Thompson; Ajay Jain; Drew M Pardoll; Richard D Schulick, Cancer research, 67(20):10058 - 66, 2007年10月
  • Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma., Yukihiko Kato; Kiyoshi Yoshimura; Tahiro Shin; Henk Verheul; Hans Hammers; Tolib B Sanni; Brenda C Salumbides; Karen Van Erp; Richard Schulick; Roberto Pili, Clinical cancer research : an official journal of the American Association for Cancer Research, 13(15 Pt 1):4538 - 46, 2007年08月
  • A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexes., Jonathan R Brody; Eike Gallmeier; Kiyoshi Yoshimura; Tomas Hucl; Peter Kulesza; Marcia I Canto; Ralph H Hruban; Richard D Schulick; Scott E Kern, Cancer biology & therapy, 5(8):923 - 7, 2006年08月
  • Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis., Sudarshan Anand; Pu Wang; Kiyoshi Yoshimura; In-Hak Choi; Anja Hilliard; Youhai H Chen; Chyung-Ru Wang; Richard Schulick; Andrew S Flies; Dallas B Flies; Gefeng Zhu; Yanhui Xu; Drew M Pardoll; Lieping Chen; Koji Tamada, The Journal of clinical investigation, 116(4):1045 - 51, 2006年04月
  • Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity., Camie W Chan; Emily Crafton; Hong-Ni Fan; James Flook; Kiyoshi Yoshimura; Mario Skarica; Dirk Brockstedt; Thomas W Dubensky; Monique F Stins; Lewis L Lanier; Drew M Pardoll; Franck Housseau, Nature medicine, 12(2):207 - 13, 2006年02月
  • Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling., Rajani Ravi; Ephraim J Fuchs; Ajay Jain; Vui Pham; Kiyoshi Yoshimura; Traci Prouser; Sanju Jalla; Xianzheng Zhou; Elizabeth Garrett-Mayer; Scott H Kaufmann; Richard D Schulick; Drew M Pardoll; Atul Bedi, Cancer research, 66(3):1730 - 9, 2006年02月
  • Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes., Kiyoshi Yoshimura; Ajay Jain; Heather E Allen; Lindsay S Laird; Christina Y Chia; Sowmya Ravi; Dirk G Brockstedt; Martin A Giedlin; Keith S Bahjat; Meredith L Leong; Jill E Slansky; David N Cook; Thomas W Dubensky; Drew M Pardoll; Richard D Schulick, Cancer research, 66(2):1096 - 104, 2006年01月
  • In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses., Tahiro Shin; Kiyoshi Yoshimura; Takako Shin; Emily B Crafton; Haruo Tsuchiya; Franck Housseau; Haruhiko Koseki; Richard D Schulick; Lieping Chen; Drew M Pardoll, The Journal of experimental medicine, 201(10):1531 - 41, 2005年05月
  • Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells., Atsuhiro Araki; Shoichi Hazama; Kiyoshi Yoshimura; Shigefumi Yoshino; Norio Iizuka; Masaaki Oka, International journal of molecular medicine, 14(4):571 - 6, 2004年10月
  • [A case of disseminated tumor from cecal cancer with survival for over 5 years after twice surgical resection and systemic chemotherapy]., Takao Tamesa; Yusaku Watanabe; Kiyoshi Yoshimura; Naohide Mori; Shigeru Yamamoto; Shoichi Hazama; Akira Tangoku; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 31(11):1864 - 6, 2004年10月
  • [Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer]., Kiyoshi Yoshimura; Shoichi Hazama; Norio Iizuka; Naofumi Takano; Kohji Matsuoka; Akira Tangoku; Masaaki Oka, Gan to kagaku ryoho. Cancer & chemotherapy, 29(12):2117 - 20, 2002年11月
  • Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma., Norio Iizuka; Shoichi Hazama; Kiyoshi Yoshimura; Shigefumi Yoshino; Akira Tangoku; Koji Miyamoto; Kiwamu Okita; Masaaki Oka, International journal of cancer, 99(2):286 - 91, 2002年05月
  • Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Ig kappa leader sequence, K Yoshimura; S Hazama; N Iizuka; S Yoshino; K Yamamoto; M Muraguchi; Y Ohmoto; T Noma; M Oka, CANCER GENE THERAPY, 8(1):9 - 16, 2001年01月
  • Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na+, K+-ATPase, N Iizuka; K Miyamoto; A Tangoku; H Hayashi; S Hazama; S Yoshino; K Yoshimura; K Hirose; H Yoshida; M Oka, BRITISH JOURNAL OF CANCER, 83(9):1209 - 1215, 2000年11月
  • Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6, N Iizuka; K Miyamoto; S Hazama; S Yoshino; K Yoshimura; K Okita; T Fukumoto; S Yamamoto; A Tangoku; M Oka, CANCER LETTERS, 158(1):35 - 41, 2000年09月
  • RET遺伝子変異による多発性内分泌腫瘍症2A型(MEN2A)の1例, 石津 和彦; 白石 晃司; 河村 英文; 内藤 克輔; 高橋 徹; 吉村 清; 丹黒 章; 白濱 秀也, 泌尿器科紀要, 45(6):407 - 410, 1999年06月
  • Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo, S. Hazama; T. Noma; F. Wang; N. Iizuka; Y. Ogura; K. Yoshimura; E. Inoguchi; M. Hakozaki; K. Hirose; T. Suzuki; M. Oka, British Journal of Cancer, 80(9):1420 - 1426, 1999年

講演・口頭発表等

  • がん薬物療法のマネジメントを促進するアセスメント・リスク管理シートの有用性の検討, 本間　織重;渡邊　知映;福地本　晴美;柏崎　純子;園生　容子;我妻　志保;細沼　雅弘;久保田　祐太郎;倉増　敦朗;堀池　篤;石田　博雄;嶋田　顕;角田　卓也;梅田　恵;吉村　清, 第59回日本癌治療学会学術集会, 2021年10月23日, 横浜・LIVE配信・オンデマンド配信
  • 抗PD-1抗体で発症せず、抗PD-L1抗体投与後に血球貪食症候群様の免疫関連有害事象を発症した肺癌症例, 有泉　裕嗣;吉村　清;堀池　篤;平澤　優弥;石黒　智之;大熊　遼太朗;久保田　祐太郎;濵田　和幸;和田　聡;鶴谷　純司;角田　卓也, 第25回日本がん免疫学会総会, 2021年07月03日, 和歌山
  • 腸内細菌叢を介したがん免疫微小環境修飾によるがん患者の予後予測マーカーの同定に関する研究, 三邉　武彦;吉村　清;濵田　和幸;久保田　祐太郎;平澤　優弥;肥田　典子;龍　家圭;諸星　北人;角田　卓也;小林　真一;内田　直樹, 第40回日本臨床薬理学会学術総会, 2019年12月06日

共同研究・競争的資金等の研究課題

  • 感染症パンデミックに耐えうるがん看護システム構築のための有害事象評価シートの開発, 本間織重、渡邊知映、角田卓也、吉村清, 研究代表者, 文部科学省, 科学研究費助成事業（基金）, 基盤研究C, 23K10046, 研究開始 202304, 配分額(総額) 4810000, 配分額(直接経費) 3700000, 配分額(間接経費) 1110000, 競争的資金
  • 外来でがん薬物療法有害事象評価シートを活用した診察前問診の有用性の検討, 本間　織重、梅田　恵、角田　卓也、吉村　清, 研究代表者, 文部科学省, 科学研究費助成事業（基金）, 基盤研究C, 20K10768, 研究開始 202009, 配分額(総額) 4290000, 配分額(直接経費) 3300000, 配分額(間接経費) 990000, 競争的資金

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.